Aratana Therapeutics Inc. (PETX) announced Monday morning that the FDA's Center for Veterinary Medicine has approved GALLIPRANT for the control of pain and inflammation associated with osteoarthritis in dogs.
from RTT - Before the Bell http://ift.tt/1pZynZl
via IFTTT
No comments:
Post a Comment